Group Introduction
Jilin Province Zhongke Jingyan Health Industry Group, established in 2013, initially engaged in pharmaceutical clinical trial services. With the company's development, it has gradually grown into a large health industry group encompassing health food, pharmaceutical R&D, pharmaceutical clinical trials, and medical device R&D and sales.
The group owns independent R&D platforms, technology transformation platforms, and sales platforms. It can independently develop and participate in the R&D of health food, pharmaceuticals, and medical devices. Nearly 100 new medical products have been successfully researched and transformed, more than 17 national and provincial and municipal science and technology projects have been independently and jointly participated in, 23 patents are under application, 7 patents have been approved, 108 approvals have been obtained, 36 approvals are pending, there is a 21-person R&D team, 5 marketing planning teams across various channels, and 6 production or registrant enterprises in five provinces, located in Jilin, Liaoning, Hunan, Guangxi, and Guizhou. At the same time, 1 clinical trial CRC company and 2 CRO companies have been established in Changchun. In recent years, in order to strengthen the company's innovative R&D capabilities, we have successively established joint laboratories with 3 large and medium-sized colleges and research institutions, and cooperated with 136 brands including Beijing Tongrentang, Renhe, Xiu Zheng, and Kuaizhihua. At the same time, we actively carry out integrated production, education, and research, and cooperate with Jilin Provincial Institute of Pharmaceutical Sciences, Jilin University, Chinese Academy of Sciences, Changchun University of Technology, Changchun University of Traditional Chinese Medicine, Soochow University, Xi'an Jiaotong University and other universities, as well as more than 4,000 medical institutions nationwide on products and technology.
